Sandbox chemo2
5+2 - Used for acute myelogenous leukemia, reinduction
Cytarabine 100 to 200 mg/m(2)/day IV, continuous infusion days 1 to 5
WITH
DAUNOrubicin 45 mg/m(2) IV, days 1 to 2
OR
MitoXANTRONE 12 mg/m(2) IV, days 1 to 2
7+3 - Used for acute myelogenous leukemia, induction
Cytarabine 100 to 200 mg/m(2)/day, continuous infusion days 1 to 7
WITH
DAUNOrubicin 45 mg/m(2) IV, days 1 to 3
OR
Idarubicin 12 mg/m(2) IV, days 1 to 3
OR
MitoXANTRONE 12 mg/m(2) IV, days 1 to 3
ABVD - Used for Hodgkin's disease
Doxorubicin 25 mg/m(2) IV, days 1 and 15
Bleomycin 10 units/m(2) IV, days 1 and 15
VinBLAStine 6 mg/m(2) IV, days 1 and 15
Dacarbazine 350 to 375 mg/m(2) IV, days 1 and 15
Repeat cycle every 28 days
AC - Used for multiple myeloma
Doxorubicin 30 mg/m(2) IV, day 1
Carmustine 30 mg/m(2) IV, day 1
Repeat cycle every 21 to 28 days
AC - Used for breast cancer
Doxorubicin 60 mg/m(2) IV, day 1
Cyclophosphamide 600 mg/m(2) IV, day 1
Repeat cycle every 21 days 
Sequential AC-Paclitaxel - Used for breast cancer
Doxorubicin 60 mg/m(2) IV, day 1; given concomitantly with
Cyclophosphamide 600 mg/m(2) IV day 1; followed by
Paclitaxel 175 to 225 mg/m(2) IV, day 1
Repeat every 21 days for 4 cycles 
Doxorubicin 60 mg/m(2) IV on day 1, every 21 days, for 4 cycles
Cyclophosphamide 600 mg/m(2) IV on day 1, every 21 days, for 4 cycles; followed by
Paclitaxel 80 mg/m(2) IV, day 1 (repeat every 7 days for 12 cycles) OR 175 mg/m(2) IV over 3 hr, day 1 (repeat every 21 days for 4 cycles) 
Dose-Dense AC-T - Used for breast cancer
Doxorubicin 60 mg/m(2) IV, day 1; given concomitantly with
Cyclophosphamide 600 mg/m(2) IV day 1, repeat every 14 days for 4 cycles; followed by
Paclitaxel 175 mg/m(2) IV, day 1, repeat every 14 days for 4 cycles
Patients undergoing treatment with this regimen should receive primary prophylaxis for neutropenia .
Sequential AC followed by T with Trastuzumab - Used for breast cancer
Doxorubicin 60 mg/m(2) IV on day 1, given concomitantly with
Cyclophosphamide 600 mg/m(2) IV on day 1, every 21 days, for 4 cycles; followed by
Paclitaxel 80 mg/m(2) IV, day 1 (repeat every 7 days for 12 cycles) OR 175 mg/m(2) IV over 3 hr, day 1 (repeat every 21 days for 4 cycles)
Trastuzumab 4 mg/kg IV infuse over 90 min, day 1, with first dose of paclitaxel, and followed by weekly doses of 2 mg/kg IV infuse over 30 min for 51 weeks 
AD - Used for sarcoma
Doxorubicin 22.5 mg/m(2)/day continuous infusion, days 1 to 4
Dacarbazine 225 mg/m(2)/day continuous infusion, days 1 to 4
Repeat cycle every 21 days
AP - Used for endometrial cancer
Doxorubicin *60 mg/m(2) IV, day 1
Cisplatin 50 mg/m(2) IV, day 1
Repeat cycle every 21 days 
- Patients who had received prior pelvic radiotherapy or who were older than 65 years were to receive doxorubicin 45 mg/m(2)
Dose-Dense A-T-C - Used for breast cancer
Doxorubicin 60 mg/m(2) IV, every 2 weeks for 4 cycles followed by
Paclitaxel 175 mg/m(2) IV, every 2 weeks for 4 cycles followed by
Cyclophosphamide 600 mg/m(2) IV, every 2 weeks for 4 cycles
Repeat every 14 days for 4 cycles
Patients undergoing treatment with this regimen should receive primary prophylaxis for neutropenia .
BEP - Used for testicular cancer
Bleomycin 30 units IV, days 2, 9, and 16
Etoposide 100 mg/m(2) IV, days 1 to 5
Cisplatin 20 mg/m(2) IV, days 1 to 5
Repeat cycle every 21 days
CAE (ACE) - Used for lung cancer, small cell
Cyclophosphamide 1000 mg/m(2) IV, day 1
Doxorubicin 45 mg/m(2) IV, day 1
Etoposide 50 mg/m(2) IV, days 1 to 5
Repeat cycle every 21 days
CAF (FAC) - Used for breast cancer
Cyclophosphamide 100 mg/m(2) ORALLY, days 1 to 14 OR 600 mg/m(2) IV, day 1
Doxorubicin 25 mg/m(2) IV, days 1 and 8 OR 60 mg/m(2) IV, day 1
Fluorouracil 500 to 600 mg/m(2) IV, days 1 and 8
Repeat cycle every 28 days
OR
Fluorouracil 500 mg/m(2) IV, days 1 and 8
Doxorubicin 50 mg/m(2) IV, day 1
Cyclophosphamide 500 mg/m(2) IV, day 1
Repeat cycle every 21 days 
Capecitabine + Docetaxel - Used for breast cancer
Capecitabine 1250 mg/m(2) ORALLY 2 times/day, days 1 through 14
Docetaxel 75 mg/m(2) IV, day 1
Repeat cycle every 21 days 
CAPOX - Used for colon cancer
Capecitabine 1000 mg/m(2) ORALLY 2 times a day, days 1 to 14
Oxaliplatin 70 mg/m(2) IV, day 8
Repeat cycle every 21 days
Carboplatin Etoposide - Used for lung cancer, non-small cell
Carboplatin 100 mg/m(2) IV, days 1 through 3
Etoposide 120 mg/m(2) IV, days 1 through 3
Repeat cycle every 28 days
OR
Carboplatin 300 mg/m(2) IV, day 1
Etoposide 100 mg/m(2) IV, days 1 through 3
Repeat cycle every 21 days
Carboplatin Etoposide + Radiation therapy - Used for lung cancer, small cell
Carboplatin AUC 6 IV over 1 hr, day 1; immediately followed by
Etoposide 100 mg/m(2) IV over 2 hr, days 1 through 3
Repeat cycle every 21 days up to a total of 6 cycles
Radiation therapy (XRT) 1.5 Gray (Gy) per fraction twice daily (at least 4 to 6 hr apart) up to a total of 45 Gy, either concurrently with the first cycle or concurrently with the fourth cycle of chemotherapy 
Carboplatin Irinotecan - Used for lung cancer, non-small cell
Carboplatin AUC 5 mg/mL/min IV, day 1
Irinotecan 50 mg/m(2) IV, days 1, 8, and 15
Repeat cycle every 28 days 
Carbo-Tax - Used for adenocarcinoma of unknown primary
Paclitaxel 135 mg/m(2) IV, over 24 hours, day 1,
followed by
Carboplatin dose targeted by Calvert formula to AUC 7.5 IV
Repeat cycle every 21 days
Carbo-Tax - Used for ovarian cancer, epithelial or lung cancer, non-small cell
Paclitaxel 135 mg/m(2) IV, over 24 hours, day 1 OR 175 mg/m(2) IV, over 3 hours, day 1 followed by
Carboplatin dose targeted by Calvert formula to AUC of 7.5 IV
Repeat cycle every 21 days
CAV (VAC) - Used for lung cancer, small cell
Cyclophosphamide 750-1000 mg/m(2) IV, day 1
Doxorubicin 50 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (max 2 mg) IV, day 1
Repeat cycle every 21 days
CC - Used for ovarian cancer, epithelial
Carboplatin dose targeted by Calvert formula to AUC of 6 to 7 IV, day 1
Cyclophosphamide 600 mg/m(2) IV, day 1
Repeat cycle every 28 days
CEF - Used for breast cancer
Cyclophosphamide 75 mg/m(2)/day ORALLY on days 1 to 14
Epirubicin 60 mg/m(2)/day IV on days 1 and 8
5-fluorouracil 500 mg/m(2)/day IV on days 1 and 8
Repeat cycle every 28 days for 6 cycles 
CF - Used for head and neck/esophageal cancer
Cisplatin 100 mg/m(2) IV, day 1
Fluorouracil 1000 mg/m(2)/day, continuous infusion, days 1 to 5
Repeat cycle every 21 to 28 days
CF - Used for head and neck/esophageal cancer
Carboplatin 400 mg/m(2) IV, day 1
Fluorouracil 1000 mg/m(2)/day, continuous infusion, days 1 to 5
Repeat cycle every 21 to 28 days
CFM (CNF, FNC) - Used for breast cancer
Cyclophosphamide 500 to 600 mg/m(2) IV, day 1
Fluorouracil 500 to 600 mg/m(2) IV, day 1
MitoXANTRONE 10 to 12 mg/m(2) IV, day 1
Repeat cycle every 21 days
ChlVPP - Used for Hodgkin's disease
Chlorambucil 6 mg/m(2) ORALLY, days 1 to 14
VinBLAStine 6 mg/m(2) IV, days 1 and 8
Procarbazine 100 mg/m(2) ORALLY, days 1 to 14
Prednisone 40 mg/day ORALLY, days 1 to 14
Repeat cycle every 28 days
CHOP - Used for lymphoma, non-Hodgkin's
Cyclophosphamide 750 mg/m(2) IV, day 1
Doxorubicin 50 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (max 2 mg) IV, day 1
Prednisone 100 mg/day ORALLY, days 1 to 5
Repeat cycle every 21 days
CISCA - Used for bladder cancer
Cyclophosphamide 650 mg/m(2) IV, day 1
Doxorubicin 50 mg/m(2) IV, day 1
Cisplatin 70 to 100 mg/m(2) IV, day 2
Repeat cycle every 21 to 28 days
Cisplatin Vinorelbine - Used for lung cancer, non-small cell
Cisplatin 50 mg/m(2) IV, days 1 and 8
Vinorelbine 25 mg/m(2) IV, one time weekly for 16 weeks
Repeat cycle every 4 weeks for 4 cycles 
Cisplatin + Vinorelbine - Used for lung cancer, non-small cell
Cisplatin 50 mg/m(2) IV, days 1 and 8
OR
Cisplatin 100 mg/m(2) IV, day 1 only
WITH
Vinorelbine 25 mg/m(2) IV, one time weekly for 16 weeks
OR
Vinorelbine 30 mg/m(2) IV, one time weekly
Repeat cycle every 4 weeks
Cisplatin Etoposide - Used for lung cancer, non-small cell
Cisplatin 100 mg/m(2) IV, day 1
Etoposide 100 mg/m(2) IV, days 1 to 3
Repeat cycle every 4 weeks 
Cisplatin VinBLAStine - Used for lung cancer, non-small cell
Cisplatin 80 mg/m(2) IV, day 1
VinBLAStine 4 mg/m(2) IV, 1 time weekly for 5 weeks (days 1 to 29 of cycle)
VinBLAStine 4 mg/m(2) IV, every 2 weeks (day 43 of cycle until last cisplatin dose) 
CLD-BOMP - Used for cervical cancer
Bleomycin 5 mg continuous infusion, days 1 to 7
Cisplatin 10 mg/m(2) IV, over 4 hours, days 1 and 22
Vincristine 0.7 mg/m(2) (max 2 mg) IV, day 7
Mitomycin 7 mg/m(2) IV, day 7
Repeat cycle every 21 days
CMF - Used for breast cancer
Cyclophosphamide 100 mg/m(2) P0, days 1 to 14
Methotrexate 40 mg/m(2) IV, days 1 and 8
Fluorouracil 600 mg/m(2) IV, days 1 and 8
Repeat cycle every 28 days 
CMV - Used for bladder cancer
Cisplatin 100 mg/m(2) IV, day 2 (12 hours after methotrexate)
Methotrexate 30 mg/m(2) IV, days 1 and 8
VinBLAStine 4 mg/m(2) IV, days 1 and 8
Repeat cycle every 21 days
CNOP - Used for lymphoma, non-Hodgkin's
Cyclophosphamide 750 mg/m(2) IV, day 1
MitoXANTRONE 10 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (max 2 mg) IV, day 1
Prednisone 50 mg/m(2) ORALLY, days 1 to 5
Repeat cycle every 21 days
COMLA - Used for lymphoma, non-Hodgkin's
Cyclophosphamide 1500 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (max 2 mg) IV, days 1, 8, and 15
Methotrexate 120 mg/m(2) IV, days 22, 29, 36, 43, 50, 57, 64, and 71
Leucovorin 25 mg/m(2) ORALLY, every 6 hours for 4 doses beginning 24 hours after each methotrexate dose
Cytarabine 300 mg/m(2) IV, days 22, 29, 36, 43, 50, 57, 64, and 71
Repeat cycle every 12 weeks
COP - Used for lymphoma, non-Hodgkin's
Cyclophosphamide 800 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (max 2 mg) IV, day 1
Prednisone 60 mg/m(2) ORALLY, days 1 to 5
Repeat cycle every 14 days
CP - Used for ovarian cancer, epithelial
Cyclophosphamide 750 mg/m(2) IV, day 1
Cisplatin 75 mg/m(2) IV, day 1
Repeat cycle every 21 days
CT - Used for ovarian cancer, epithelial
Paclitaxel 135 mg/m(2) IV, over 24 hours, day 1 OR 175 mg/m(2) IV, over 3 hours, day 1 followed by
Cisplatin 75 mg/m(2) IV
Repeat cycle every 21 days
CVD - Used for melanoma
Cisplatin 20 mg/m(2) IV, days 2 to 5
VinBLAStine 1.6 mg/m(2) IV, days 1 to 5
Dacarbazine 800 mg/m(2) IV, day 1
Repeat cycle every 21 days
CVD+IL-2 - Used for melanoma
Cisplatin 20 mg/m(2) IV, days 1 to 4
VinBLAStine 1.6 mg/m(2) IV, days 1 to 4
Dacarbazine 800 mg/m(2) IV, day 1
IL-2, 9 million units/m(2) continuous infusion, days 1 to 4
Interferon alfa 5 million units/m(2) subQ, days 1 to 5, 7, 9, 11, and 13
Repeat cycle every 21 days
CYVADIC - Used for sarcoma
Cyclophosphamide 500 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (max 2 mg) IV, days 1 and 5
Doxorubicin 50 mg/m(2) IV, day 1
Dacarbazine 250 mg/m(2) IV, days 1 to 5
Repeat cycle every 21 days
Dacarbazine Tamoxifen - Used for melanoma
Dacarbazine 250 mg/m(2) IV, days 1 to 5, every 21 days
Tamoxifen 20 mg/day ORALLY
The use of tamoxifen is optional
DHAP - Used for lymphoma, non-Hodgkin's
Dexamethasone 40 mg ORALLY or IV, days 1 to 4
Cisplatin 100 mg/m(2)/day, continuous infusion, day 1
Cytarabine 2000 mg/m(2) IV, every 12 hours for 2 doses, day 2
Administer with saline methylcellulose, or steroid eyedrops in both eyes, every 2 to 4 hours, beginning with cytarabine and continuing 48 to 72 hours after the last cytarabine dose.
Repeat cycle every 21 to 28 days
DI - Used for sarcoma
Doxorubicin 50 mg/m(2) IV, bolus, day 1
Ifosfamide 5000 mg/m(2)/day continuous infusion, following doxorubicin, day 1
Mesna 600 mg/m(2) IV, bolus before ifosfamide, followed by 2500 mg/m(2)/day continuous infusion, for 36 hours
Repeat cycle every 21 days
Docetaxel Cisplatin - Used for lung cancer, non-small cell
Docetaxel 75 mg/m(2) IV, day 1
Cisplatin 75 mg/m(2) IV, day 1
Repeat cycle every 3 weeks 
Docetaxel Estramustine - Used for prostate cancer
Docetaxel 60 mg/m(2) IV, day 2
Estramustine 280 mg ORALLY, 3 times/day, days 1 through 5
Repeat cycle every 21 days 
Docetaxel Gemcitabine - Used for bladder cancer
Docetaxel 40 mg/m(2) IV, days 1 and 8
Gemcitabine 800 mg/m(2) IV, days 1 and 8
Repeat cycle every 21 days 
Docetaxel Prednisone - Used for prostate cancer
Docetaxel 30 mg/m(2) IV, days 1, 8, 15, 22, and 29 of a 6 week cycle
OR
Docetaxel 75 mg/m(2) IV, day 1; repeat every 21 days
Prednisone 5 mg ORALLY, 2 times/day
Repeat cycle every 21 days 
Docetaxel with Trastuzumab followed by FEC - Used for breast cancer
Trastuzumab 4 mg/kg IV infuse over 90 min, once only with the first cycle of docetaxel THEN 2 mg/kg IV infuse over 30 min 1 times weekly for 9 weeks; infuse trastuzumab before docetaxel; no trastuzumab during FEC administration
Docetaxel 100 mg/m(2) IV over 1 hour, day 1
Repeat every 21 days for 3 cycles
After completion of 3 cycles of docetaxel and 9 weekly infusions of trastuzumab, begin 3 cycles of FEC
5-fluorouracil 600 mg/m(2) IV, day 1
Epirubicin 60 mg/m(2) IV, day 1
Cyclophosphamide 600 mg/m(2) IV, day 1
Repeat every 21 days for 3 cycles 
Sequential Dox-CMF - Used for breast cancer
Four courses of doxorubicin followed by 8 courses of CMF for a total of 12 courses
Doxorubicin 75 mg/m(2) IV, day 1
Repeat every 21 days for 4 cycles
Start CMF after the fourth cycle of doxorubicin
Cyclophosphamide 600 mg/m(2) IV, day 1
Methotrexate 40 mg/m(2) IV, day 1
5-fluorouracil 600 mg/m(2) IV, day 1
Repeat every 21 days for 8 cycles 
EAP - Used for gastric cancer
Etoposide 120 mg/m(2) IV, days 4, 5, and 6
Doxorubicin 20 mg/m(2) IV, days 1 and 7
Cisplatin 40 mg/m(2) IV, days 2 and 8
Repeat cycle every 21 to 28 days
EC - Used for breast cancer
Epirubicin 100 mg/m(2) IV, day 1
Cyclophosphamide 830 mg/m(2) IV, day 1
Repeat cycle every 21 days 
Epirubicin 75 mg/m(2) IV, day 1; followed by
Cyclophosphamide 600 mg/m(2) IV, day 1
Repeat cycle every 21 days for a maximum of 6 cycles 
EC - Used for lung cancer, non-small cell
Etoposide 100 to 120 mg/m(2) IV, days 1 to 3
WITH
Carboplatin 300 to 325 mg/m(2) IV, day 1
Repeat cycle every 21 to 28 days
EC - Used for lung cancer, small cell
Etoposide 100 to 120 mg/m(2) IV, days 1 to 3
Carboplatin 325 to 450 mg/m(2) IV, day 1
Repeat cycle every 28 days
ELF - Used for gastric cancer
Leucovorin 150 to 300 mg/m(2) IV, over 10 minutes
FOLLOWED BY
Etoposide 120 mg/m(2) IV, over 50 minutes
FOLLOWED BY
Fluorouracil 500 mg/m(2) IV, over 10 minutes
All drugs are given on days 1 to 3
Repeat cycle every 21 to 28 days
EMA-86 - Used for acute myelogenous leukemia, induction
Etoposide 200 mg/m(2)/day continuous infusion, days 8 to 10
MitoXANTRONE 12 mg/m(2) IV, days 1 to 3
Cytarabine 500 mg/m(2)/day continuous infusion, days 1 to 3 and 8 to 10
EP - Used for adenocarcinoma of unknown primary
Cisplatin 60 to 100 mg/m(2) IV, day 1
Etoposide 80 to 100 mg/m(2) IV, days 1 to 3
Repeat cycle every 21 days
EP - Used for testicular cancer
Etoposide 100 mg/m(2) IV, days 1 to 5
Cisplatin 20 mg/m(2) IV, days 1 to 5
Repeat cycle every 21 days
EP - Used for lung cancer, non-small cell
Etoposide 80 mg/m(2) IV, days 1 to 3
Cisplatin 60 to 100 mg/m(2) IV, day 1
Repeat cycle every 21 to 28 days
EP (PE) - Used for lung cancer, small cell
Etoposide 120 mg/m(2) IV, days 1 to 3
Cisplatin 60 to 120 mg/m(2) IV, day 1
Repeat cycle every 21 to 28 days
Sequential Epirubicin-CMF - Used for breast cancer
Epirubicin 100 mg/m(2) IV, day 1, repeat every 21 days for 4 cycles
CMF for 4 cycles
CMF regimen in the National Epirubicin Adjuvant Trial (NEAT)
Cyclophosphamide 100 mg/m(2) ORALLY 1 times daily, days 1 through 14, OR 600 mg/m(2) IV on days 1 and 8
Methotrexate 40 mg/m(2) IV on day 1 and 8
5-Fluorouracil 600 mg/m(2) IV day 1 and 8
Repeat every 28 days for 4 cycles
OR
CMF regimen in the BR9601 trial
Cyclophosphamide 750 mg/m(2) IV day 1
Methotrexate 50 mg/m(2) IV day 1
5-Fluorouracil 600 mg/m(2) IV days 1
Repeat every 21 days for 4 cycles 
ESHAP - Used for lymphoma, non-Hodgkin's
Etoposide 60 mg/m(2) IV, days 1 to 4
Methylprednisolone 500 mg IV, days 1 to 4
Cisplatin 25 mg/m(2)/day continuous infusion, days 1 to 4
Cytarabine 2000 mg/m(2) IV, day 5, immediately following completion of etoposide and cisplatin infusions
Administer with saline methylcellulose, or steroid eyedrops in both eyes, every 2 to 4 hours, beginning with cytarabine and continuing 48 to 72 hours after the last cytarabine dose.
Repeat cycle every 21 to 28 days
Estramustine VinBLAStine - Used for prostate cancer
Estramustine 200 mg/m(2) ORALLY, 3 times a day, days 1 to 42
VinBLAStine 4 mg/m(2) IV, weekly for 6 weeks, begin day 1
Repeat cycle every 6 weeks
Etoposide Cisplatin - Used for lung cancer, small cell
Etoposide 100 mg/m(2) IV, day 1
Etoposide 200 mg/m(2) IV, days 2 through 4
Cisplatin 75 mg/m(2) IV, day 1
Repeat cycle every 21 days
OR
Etoposide 80 mg/m(2) IV, days 1 through 3
Cisplatin 80 mg/m(2) IV, day 1
Repeat cycle every 21 days 
EVA - Used for Hodgkin's disease
Etoposide 100 mg/m(2) IV, days 1 to 3
VinBLAStine 6 mg/m(2) IV, day 1
Doxorubicin 50 mg/m(2) IV, day 1
Repeat cycle every 28 days
FAM - Used for gastric cancer
Fluorouracil 600 mg/m(2) IV, days 1, 8, 29, and 36
Doxorubicin 30 mg/m(2) IV, days 1 and 29
Mitomycin C 10 mg/m(2) IV, day 1
Repeat cycle every 8 weeks
FAM - Used for adenocarcinoma of unknown primary
Fluorouracil 600 mg/m(2) IV, over 1 hour, days 1, 8, 29, and 36
Doxorubicin 30 mg/m(2) IV, days 1 and 29
Mitomycin 10 mg/m(2) IV, day 1
Repeat cycle every 8 weeks
FAM - Used for pancreatic cancer
Fluorouracil 600 mg/m(2) IV, days 1, 8, 29, and 36
Doxorubicin 30 mg/m(2) IV, days 1 and 29
Mitomycin 10 mg/m(2) IV, day 1
Repeat cycle every 72 days
FAMTX - Used for gastric cancer
Methotrexate 1500 mg/m(2) IV, day 1
Fluorouracil 1500 mg/m(2) IV, starting 1 hour after methotrexate, day 1
Leucovorin 15 mg/m(2) ORALLY, every 6 hours, beginning 24 hours after methotrexate, continue until methotrexate concentration is less than 2 X 10(-8) (increase dose to 30 mg/m(2) if methotrexate concentration is greater than or equal to 2.5 X 10(-6) at 24 hours)
Doxorubicin 30 mg/m(2) IV, day 15
Repeat cycle every 28 days
FC - Used for chronic lymphocytic leukemia
Fludarabine 25 mg/m(2)/day IV over 3 days
Cyclophosphamide 250 mg/m(2)/day IV over 3 days
Repeat cycle every 28 days 
FEC - Used for breast cancer
5-fluorouracil 500 mg/m(2) IV, days 1 and 8
Epirubicin 50 mg/m(2) IV, days 1 and 8
Cyclophosphamide 400 mg/m(2) IV, days 1 and 8
Repeat cycle every 28 days 
FEC followed by T - Used for breast cancer
5-fluorouracil 500 mg/m(2) IV, day 1
Epirubicin 100 mg/m(2) IV, day 1
Cyclophosphamide 500 mg/m(2) IV, day 1
Docetaxel 100 mg/m(2) IV, day 1
Repeat every 21 days for 3 cycles 
FEC-100 - Used for breast cancer
5-fluorouracil 500 mg/m(2) IV on day 1
Epirubicin 100 mg/m(2) IV on day 1
Cyclophosphamide 500 mg/m(2) IV on day 1
Repeat cycle every 21 days for 6 cycles
FL - Used for prostate cancer
Flutamide 250 mg ORALLY three times daily
Leuprolide acetate 1 mg subQ daily
OR
Flutamide 250 mg ORALLY three times daily
Leuprolide acetate depot 7.5 mg IM every 28 days
Fle - Used for colon cancer
Fluorouracil 450 mg/m(2) IVP, days 1 to 5, then at day 29, begin 450 mg/m(2) IVP, every 7 days for a total of 1 year of therapy
Levamisole 50 mg ORALLY, every 8 hours for 3 days, repeated every 14 days for 52 weeks 
FLOX- Used for colon cancer
Oxaliplatin 85 mg/m(2) IV, infuse over 2 hr before leucovorin and fluorouracil on days 1, 15, and 29
Leucovorin 500 mg/m(2) infuse over 2 hr weekly on days 1, 8, 15, 22, 29, and 36 followed by a 2-week rest period
Fluorouracil 500 mg/m(2) IV bolus 1 hr after the leucovorin is begun; weekly on days 1, 8, 15, 22, 29, and 36 followed by a 2-week rest period
Three 8-week cycles of therapy for total treatment duration of 6 months 
Fluorouracil Leucovorin - Used for colon cancer
Leucovorin 500 mg/m(2) IV, over 2 hours, 6 times weekly , followed by a 2-week rest period
Fluorouracil 500 mg/m(2) IVP, 1 hour after initiating leucovorin infusion, 6 times weekly, followed by a 2-week rest period
Repeat every 8 weeks for 4 cycles 
OR
Leucovorin 20 mg/m(2) IVP, days 1 to 5
Fluorouracil 425 mg/m(2) IVP, following leucovorin, days 1 to 5
Repeat cycle at 4 weeks, 8 weeks, and every 5 weeks for 6 courses 
OR
LV5FU2 Regimen
Leucovorin 200 mg/m(2)/day as a 2-hour IV infusion, days 1 and 2
Fluorouracil 400 mg/m(2)/day IV bolus following leucovorin, days 1 and 2
Fluorouracil 600 mg/m(2)/day as a 22-hour infusion, days 1 and 2
Repeat every 2 weeks 
OR
Leucovorin 20 mg/m(2) IV over 2 hours
Fluorouracil 500 mg/m(2) IV bolus one hour after leucovorin
Repeat weekly 
Fluorouracil Leucovorin Bevacizumab - Used for colorectal cancer
Fluorouracil 500 mg/m(2) IV once weekly for 6 weeks
Leucovorin 500 mg/m(2) IV every 8 weeks
Bevacizumab 5 mg/kg IV every 2 weeks 
Fluorouracil Leucovorin Levamisole - Used for colon cancer
Fluorouracil 425 mg/m(2) IVP days 1 to 5
Leucovorin 20 mg/m(2) IVP days 1 to 5
Repeat ever 4 weeks, 8 weeks, and every 5 weeks for 6 courses; administer with
Levamisole 50 mg ORALLY, every 8 hours for 3 days, repeated every 14 days for 6 months 
FOLFIRI - Used for colorectal cancer
Irinotecan 180 mg/m(2) IV, day 1; with
Fluorouracil 400 mg/m(2) bolus; and
Fluorouracil 600 mg/m(2) by 22 hr infusion; plus
Leucovorin 400 mg/m(2) IV days 1 and 2
Repeat every 2 weeks until disease progression or intolerable toxicity 
Alternative regimen:
Irinotecan 180 mg/m(2) IV over 90 minutes, day 1
Leucovorin 400 mg/m(2) IV over 2 hours during irinotecan, day 1
Fluorouracil 400 mg/m(2) IV bolus followed by
Fluorouracil 2.4 g/m(2) (first 2 cycles) to 3 g/m(2) (subsequent cycles) IV over 46 hours continuous infusion
Repeat every 2 weeks until disease progression or intolerable toxicity 
FOLFIRINOX - Used for metastatic pancreatic cancer
Oxaliplatin 85 mg/m(2) IV over 2 hours, immediately followed by
Leucovorin 400 mg/m(2) IV over 2 hours
Irinotecan 180 mg/m(2) IV over 90 minutes through a Y-connector (30 minutes after leucovorin), immediately followed by
Fluorouracil 400 mg/m(2) IV bolus followed by
Fluorouracil 2.4 g/m(2) IV over 46 hours continuous infusion
Repeat every 2 weeks for 6 months 
FOLFOX 4 - Used for colorectal cancer
Oxaliplatin 85 mg/m(2) IV over 2 hours, day 1, same time as leucovorin (different lines)
Leucovorin 200 mg/m(2)/day or l-leucovorin 100 mg/m(2) IV over 2 hours, days 1 and 2, before fluorouracil on each day
Fluorouracil 400 mg/m(2)/day IV bolus, days 1 and 2, followed by
Fluorouracil 600 mg/m(2)/day as a continuous IV infusion over 22 hours, days 1 and 2
Repeat every 2 weeks 
FOLFOX 6 - Used for colorectal cancer
Oxaliplatin 100 mg/m(2) IV over 2 hours, day 1, same time as leucovorin (different lines)
Leucovorin 400 mg/m(2) or l-leucovorin 200 mg/m(2) IV over 2 hours, day 1, before fluorouracil on day 1
Fluorouracil 400 mg/m(2) IV bolus once on day 1 only followed by
Fluorouracil 2.4 to 3 g/m(2)- as a continuous IV infusion over 46 hours
Repeat every 2 weeks 
- 2.4 g/m(2) for the first 2 cycles, increased to 3 g/m(2) thereafter if no toxicity greater than grade 1 
Modified FOLFOX 6 - Used for colorectal cancer
Oxaliplatin 85 mg/m(2) IV over 2 hours, day 1, same time as leucovorin (different lines)
Leucovorin 400 mg/m(2) or l-leucovorin 200 mg/m(2) IV over 2 hours, day 1, before fluorouracil on day 1
Fluorouracil 400 mg/m(2) IV bolus once on day 1 only followed by
Fluorouracil 2.4 g/m(2) as a continuous IV infusion over 46 or 48 hours
Repeat every 2 weeks 
FOLFOX 7 - Used for colorectal cancer
Oxaliplatin 130 mg/m(2) IV over 2 hours, day 1, same time as leucovorin (different lines)
Leucovorin 400 mg/m(2) or l-leucovorin 200 mg/m(2) IV over 2 hours, day 1, before fluorouracil on day 1
Fluorouracil 2.4 g/m(2) as a continuous IV infusion over 46 hours
Repeat every 2 weeks 
FZ - Used for prostate cancer
Flutamide 250 mg ORALLY, 3 times/day
Goserelin acetate 3.6-mg implant subQ every 28 days
OR
Flutamide 250 mg ORALLY, 3 times/day
Goserelin acetate 10.8-mg implant subQ every 12 weeks
GC - Used for bladder cancer
Gemcitabine 1000 mg/m(2) IV, days 1, 8, and 15
Cisplatin 70 mg/m(2) IV, day 2
Repeat cycle every 28 days
GDP - Used for lymphoma, non-Hodgkin's
Gemcitabine 1000 mg/m(2) IV over 30 minutes, days 1 and 8
Dexamethasone 40 mg ORALLY in divided doses, days 1 through 4
Cisplatin 75 mg/m(2) IV over 60 minutes, day 1
Repeat cycle every 21 days 
Gemcitabine-Cis - Used for lung cancer, non-small cell
Gemcitabine 1000 mg/m(2) IV, days 1, 8, and 15
Cisplatin 100 mg/m(2) IV, day 2 or 15
Repeat cycle every 28 days
Gemcitabine Paclitaxel - Used for bladder cancer
Gemcitabine 1000 mg/m(2) IV, days 1, 8, and 15
Paclitaxel 200 mg/m(2) IV, day 1
Repeat cycle every 21 days 
GT - Used for breast cancer
Paclitaxel 175 mg/m(2) IV, day 1
Gemcitabine 1250 mg/m(2) IV, days 1 and 8
Repeat cycle every 21 days 
ICE - Used for lymphoma, non-Hodgkin's
Regimen # 1
Etoposide 100 mg/m(2) IV bolus, days 1 to 3
Carboplatin AUC 5, MAX 800 mg, IV bolus on day 2
Ifosfamide 5000 mg/m(2), admixed with mesna 5000 mg/m(2), IV continuous infusion over 24 hours on day 2
Filgrastim (G-CSF) 5 mcg/kg/day, days 5 to 12 for cycles 1 and 2, then 10 mcg/kg/day after the third cycle until the end of leukapheresis
Repeat cycle every 14 days for 3 cycles 
Regimen # 2
Ifosfamide 1000 mg/m(2)/day over 1 hour days 1 to 2 (hours 0 and 1)
Etoposide 150 mg/m(2)/day IV over 11 hours after ifosfamide days 1 to 2 (hours 1 to 11)
Carboplatin 200 mg/m(2)/day IV over 1 hour after etoposide days 1 to 2 (hours 11 to 12)
Etoposide 150 mg/m(2)/day IV over 11 hours after carboplatin days 1 to 2 (hours 12 to 24)
Mesna 333 mg/m(2) IV 30 minutes before ifosfamide, repeat 4 and 8 hours after ifosfamide
Repeat cycle every 4 weeks for 2 cycles
IE - Used for sarcoma
Etoposide 100 mg/m(2) IV, days 1 to 5
Ifosfamide 1800 mg/m(2) IV, days 1 to 5
Mesna at 20% of ifosfamide dose prior to and 4 and 8 hours after ifosfamide administration
Repeat cycle every 21 to 28 days
IFL - Used for colorectal cancer
Irinotecan 125 mg/m(2) IV
Fluorouracil 500 mg/m(2) IV bolus plus
Leucovorin 20 mg/m(2) IV on Days 1, 8, 15, and 22 every 6 weeks
IFL Bevacizumab - Used for colorectal cancer
Irinotecan 125 mg/m(2) IV once weekly for 4 weeks
Fluorouracil 500 mg/m(2) IV every 6 weeks
Leucovorin 20 mg/m(2) IV
Bevacizumab 5 mg/kg IV every 2 weeks 
Irinotecan Cisplatin - Used for lung cancer, small cell
Irinotecan 60 mg/m(2) IV, days 1, 8, and 15
Cisplatin 60 mg/m(2) IV, day 1
Repeat cycle every 28 days
OR
Irinotecan 65 mg/m(2) IV, days 1 and 8
Cisplatin 30 mg/m(2) IV, days 1 and 8
Repeat cycle every 21 days 
IROX - Used for colorectal cancer
Oxaliplatin 85 mg/m(2) IV
Irinotecan 200 mg/m(2) IV
Repeat every 3 weeks
Ixabepilone + Capecitabine - Used for breast cancer
Ixabepilone 40 mg/m(2) IV, day 1
Capecitabine 1000 mg/m(2) ORALLY 2 times/day, days 1 through 14
Repeat cycle every 21 days 
Lapatinib + Capecitabine - Used for breast cancer
Lapatinib 1250 mg ORALLY, days 1 through 21
Capecitabine 1000 mg/m(2) ORALLY 2 times/day, days 1 through 14
Repeat cycle every 21 days 
M2 - Used for multiple myeloma
Vincristine 0.03 mg/kg (max 2 mg) IV, day 1
Carmustine 0.5 to 1 mg/kg IV, day 1
Cyclophosphamide 10 mg/kg IV, day 1
Melphalan 0.25 mg/kg ORALLY, days 1 to 4 OR 0.1 mg/kg ORALLY, days 1 to 7 or 1 to 10
Prednisone 1 mg/kg/day ORALLY, days 1 to 7
Repeat cycle every 35 to 42 days
MACOP-B - Used for lymphoma, non-Hodgkin's
Methotrexate 400 mg/m(2) IV, weeks 2, 6, and 10
Leucovorin 15 mg/m(2) ORALLY, every 6 hours for 6 doses, beginning 24 hours after methotrexate
Doxorubicin 50 mg/m(2) IV, weeks 1, 3, 5, 7, 9, and 11
Cyclophosphamide 350 mg/m(2) IV, weeks 1, 3, 5, 7, 9, and 11
Vincristine 1.4 mg/m(2) (max 2 mg) IV, weeks 2, 4, 6, 8, 10, and 12
Prednisone 75 mg/day ORALLY, for 12 weeks, then taper over last 2 weeks
Bleomycin 10 units/m(2) IV, weeks 4, 8, and 12
Cotrimoxazole DS ORALLY, 2 times/day for 12 weeks
Ketoconazole 200 mg/day ORALLY
Administer 1 cycle
MAID - Used for sarcoma
Mesna 2500 mg/m(2)/day continuous infusion, days 1 to 4
Doxorubicin 15 mg/m(2)/day continuous infusion, days 1 to 4
Ifosfamide 2500 mg/m(2)/day continuous infusion, days 1 to 3
Dacarbazine 250 mg/m(2)/day continuous infusion, days 1 to 4
Repeat cycle every 21 to 28 days
m-BACOD - Used for lymphoma, non-Hodgkin's
Methotrexate 200 mg/m(2) IV, days 8 and 15
Leucovorin 10 mg/m(2) ORALLY, every 6 hours for 8 doses, beginning 24 hours after each methotrexate dose
Bleomycin 4 units/m(2) IV, day 1
Doxorubicin 45 mg/m(2) IV, day 1
Cyclophosphamide 600 mg/m(2) IV, day 1
Vincristine 1 mg/m(2) (max 2 mg) IV, day 1
Dexamethasone 6 mg/m(2) ORALLY, days 1 to 5
Repeat cycle every 21 days
MINE-ESHAP - Used for lymphoma, non-Hodgkin's
Mesna 1330 mg/m(2) IV, given at the same time as ifosfamide, then 500 mg ORALLY, 4 hours after ifosfamide, days 1 to 3
Ifosfamide 1330 mg/m(2) IV, over 1 hour, days 1 to 3
MitoXANTRONE 8 mg/m(2) IV, day 1
Etoposide 65 mg/m(2) IV, days 1 to 3
Repeat cycle every 21 days for 6 cycles, followed by 3 to 6 cycles of ESHAP
MitoXANTRONE Prednisone - Used for prostate cancer
MitoXANTRONE 12 mg/m(2) IV, day 1
Prednisone 5 mg ORALLY, 2 times/day
Repeat cycle every 21 days
MOBP - Used for cervical cancer
Bleomycin 30 units/day continuous infusion, days 1 and 4
Vincristine 0.5 mg/m(2) (max 2 mg) IV, days 1 and 4
Mitomycin 10 mg/m(2) IV, day 1
Cisplatin 50 mg/m(2) IV, days 1 and 22
Repeat cycle every 28 days
MOPP - Used for Hodgkin's disease, adult
Mechlorethamine 6 mg/m(2) IV, days 1 and 8
Vincristine 1.4 mg/m(2) (max 2 mg) IV, days 1 and 8
Procarbazine 100 mg/m(2) ORALLY, days 1 to 14
Prednisone 40 mg/m(2) ORALLY, days 1 to 14
Repeat cycle every 28 days
MOPP/ABV Hybrid - Used for Hodgkin's disease
Mechlorethamine 6 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (max 2 mg) IV, day 1
Procarbazine 100 mg/m(2) ORALLY, days 1 to 7
Prednisone 40 mg/m(2) ORALLY, days 1 to 14
Doxorubicin 35 mg/m(2) IV, day 8
Bleomycin 10 units/m(2) IV, day 8
VinBLAStine 6 mg/m(2) IV, day 8
Repeat cycle every 28 days
MOPP/ABVD - Used for Hodgkin's disease
Refer to MOPP doses; alternate every other month with ABVD
MP - Used for multiple myeloma
Melphalan 8 to 10 mg/m(2) ORALLY, days 1 to 4
Prednisone 40 to 60 mg/m(2)/d ORALLY, days 1 to 4
Repeat cycle every 28 to 42 days
MVAC - Used for bladder cancer
Methotrexate 30 mg/m(2) IV, days 1, 15, and 22
VinBLAStine 3 mg/m(2) IV, days 2, 15, and 22
Doxorubicin 30 mg/m(2) IV, day 2
Cisplatin 70 mg/m(2) IV, day 2
Repeat cycle every 28 days
NFL - Used for breast cancer
MitoXANTRONE 12 mg/m(2) IV, day 1
Fluorouracil 350 mg/m(2) IV, days 1 to 3 following leucovorin
Leucovorin 300 mg IV, over 1 hour, days 1 to 3
OR
MitoXANTRONE 10 mg/m(2) IV, day 1
Fluorouracil 1000 mg/m(2)/day as continuous infusion, days 1 to 3, following leucovorin
Leucovorin 100 mg/m(2) IV, over 15 minutes, days 1 to 3
Repeat cycle every 21 days
NOVP - Used for lymphoma, non-Hodgkin's
MitoXANTRONE 10 mg/m(2) IV, day 1
VinBLAStine 6 mg/m(2) IV, day 1
Prednisone 100 mg ORALLY, days 1 to 5
Vincristine 2 mg IV, day 8
Repeat cycle every 21 days
P + T followed by FEC + T - Used for breast cancer
Trastuzumab 4 mg/kg IV infuse over 90 minutes on day 1 with the first cycle of paclitaxel, THEN 2 mg/kg IV infuse over 30 minutes once a week starting with week 2 and for the duration of the 24 weeks of chemotherapy
Paclitaxel 225 mg/m(2) IV infuse over 24 hours, day 1
Repeat every 21 days for 4 cycles
After completion of 4 cycles of paclitaxel, begin 4 cycles of FEC
5-fluorouracil 500 mg/m(2) IV, days 1 and 4
Epirubicin 75 mg/m(2) IV, day 1 only
Cyclophosphamide 500 mg/m(2) IV, day 1 only
Repeat every 21 days for 4 cycles 
PAC - Used for bladder cancer
Cisplatin 100 mg/m(2) IV
Doxorubicin 60 mg/m(2) IV
Cyclophosphamide 600 mg/m(2) IV
Repeat cycle every 4 weeks 
Paclitaxel Cisplatin - Used for lung cancer, non-small cell
Paclitaxel 135 mg/m(2) IV, day 1
Cisplatin 75 mg/m(2) IV, day 2
Repeat cycle every 3 weeks 
Paclitaxel Carboplatin - Used for lung cancer, non-small cell
Adjuvant
Paclitaxel 200 mg/m(2) IV, day 1
Carboplatin AUC 6 mg/mL/min IV, day 1
Repeat cycle every 3 weeks 
Advanced
Paclitaxel 225 mg/m(2) IV, infuse over 3 hours, day 1
Carboplatin AUC 6 mg/mL/min IV, day 1
Repeat cycle every 3 weeks for 4 cycles 
Paclitaxel Carboplatin Etoposide - Used for adenocarcinoma of unknown primary
Paclitaxel 200 mg/m(2) IV, over 1 hour, day 1
Carboplatin dose targeted by Calvert formula to AUC 6 IV
Etoposide 50 mg/day ORALLY alternated with 100 mg/day ORALLY, days 1 to 10
Repeat cycle every 21 days
Paclitaxel Trastuzumab - Used for breast cancer
Paclitaxel 175 mg/m(2) IV, day 1
Trastuzumab 4 mg/kg IV, given at the same time as paclitaxel, then 2 mg/kg IV, 1 times weekly
Repeat cycle every 21 days 
PC - Used for bladder cancer
Paclitaxel 200 mg/m(2) or 225 mg/m(2) IV, over 3 hours, day 1
Carboplatin targeted by Calvert formula to AUC 5 to 6 IV after paclitaxel, day 1
Repeat cycle every 21 days
PC - Used for lung cancer, non-small cell
Paclitaxel 175 mg/m(2) IV, over 3 hours, day 1
Cisplatin 80 mg/m(2) IV, day 1
Repeat cycle every 21 days
PE - Used for prostate cancer
Paclitaxel 120 mg/m(2) continuous infusion, days 1 to 4
Estramustine 600 mg/day ORALLY, in 2 or 3 divided doses, 24 hours before paclitaxel
Repeat cycle every 21 days
PE + Radiation therapy - Used for lung cancer, non-small cell
Cisplatin 50 mg/m(2) IV on days 1, 8, 29, and 36, with
Etoposide 50 mg/m(2) IV on days 1 through 5 and 29 through 33
Radiation therapy (XRT) 1.8 Gray (Gy) per fraction 5 days a week for a total of 25 fractions (45 Gy) to the primary and mediastinum; followed by
XRT 1.8 Gy per fraction once daily in 8 fractions (14.4 Gy) to the primary and involved nodes for a total of 59.4 Gy in 33 fractions 
ProMACE/cytaBOM - Used for lymphoma, non-Hodgkin's
Prednisone 60 mg/m(2) ORALLY, days 1 to 14
Doxorubicin 25 mg/m(2) IV, day 1
Cyclophosphamide 650 mg/m(2) IV, day 1
Etoposide 120 mg/m(2) IV, day 1
Cytarabine 300 mg/m(2) IV, day 8
Bleomycin 5 units/m(2) IV, day 8
Vincristine 1.4 mg/m(2) (max 2 mg) IV, day 8
Methotrexate 120 mg/m(2) IV, day 8
Leucovorin 25 mg/m(2) ORALLY, every 6 hours for 6 doses, beginning 24 hours after methotrexate
Concomitant Cotrimoxazole DS ORALLY 2 times/day
Repeat cycle every 21 to 28 days
PVB - Used for testicular cancer
Cisplatin 20 mg/m(2) IV, days 1 to 5
VinBLAStine 0.15 mg/kg IV, days 1 and 2
Bleomycin 30 units IV, days 2, 9, and 16
Repeat cycle every 21 days
R-CHOP - Used for lymphoma, non-Hodgkin's
Rituximab 375 mg/m(2) IV, day 1
Cyclophosphamide 750 mg/m(2) IV, day 1
Doxorubicin 50 mg/m(2) IV, day 1
Vincristine 1.4 mg/m(2) (MAX 2 mg) IV, day 1
PredniSONE 40 mg/m(2)/day ORALLY, days 1 to 5
Repeat cycle every 3 weeks for 8 cycles 
RICE - Used for lymphoma, non-Hodgkin's
Rituximab 375 mg/m(2) IV day 1 of each cycle and 48 hr before first cycle initiation
Ifosfamide 5000 mg/m(2) with equal amount of mesna continuous IV infusion over 24 hr beginning day 4
Carboplatin AUC 5, capped at 800 mg, bolus infusion on day 4
Etoposide 100 mg/m(2) IV bolus daily for 3 days, on days 3 to 5
Repeat cycle every 14 days for 3 cycles
G-CSF 5 mcg/kg subQ days 7 to 14 after the first 2 cycles and 10 mcg/kg/day after the third cycle until the end of leukapheresis 
SMF - Used for pancreatic cancer
Streptozocin 1000 mg/m(2) IV, days 1, 8, 29, and 36
Mitomycin 10 mg/m(2) IV, day 1
Fluorouracil 600 mg/m(2) IV, days 1, 8, 29, and 36
Repeat cycle every 72 days
Stanford V - Used for Hodgkin's disease
Mechlorethamine 6 mg/m(2) IV, day 1
Doxorubicin 25 mg/m(2) IV, days 1 and 15
VinBLAStine- 6 mg/m(2) IV, days 1 and 15
Vincristine- 1.4 mg/m(2) (max 2 mg) IV, days 8 and 22
Bleomycin 5 units/m(2) IV, days 8 and 22
Etoposide 60 mg/m(2) IV, days 15 and 16
Prednisone 40 mg/m(2) ORALLY, every other day, taper by 10 mg every other day starting at week 10
Repeat cycle every 28 days
- In patients over 50 years old, decrease the vinBLAStine dose to 4 mg/m(2) and the vincristine dose to 1 mg/m(2) on weeks 9 to 12.
Concomitant Cotrimoxazole DS ORALLY 2 times/day; acyclovir 200 mg ORALLY 3 times/day; ketoconazole 200 mg ORALLY daily and stool softeners used.
TAC - Used for breast cancer
Doxorubicin 50 mg/m(2) IV, day 1
Cyclophosphamide 500 mg/m(2) IV, day 1
Docetaxel 75 mg/m(2) IV, day 1, one hour after cyclophosphamide
Repeat cycle every 21 days 
TAP - Used for endometrial cancer
Doxorubicin 45 mg/m(2) IV, day 1
Cisplatin 50 mg/m(2) IV, day 1
Paclitaxel 160 mg/m(2) IV over 3 hours, day 2
Filgrastim 5 mcg/kg/day subQ, days 3 to 12
Repeat cycle every 21 days for up to 7 cycles
TC - Used for breast cancer
Docetaxel 75 mg/m(2) IV, day 1
Cyclophosphamide 600 mg/m(2) IV, day 1
Repeat every 21 days for 4 cycles 
TCH (Paclitaxel/Carboplatin weekly + Trastuzumab) - Used for breast cancer
Paclitaxel 80 mg/m(2) IV over 1 hour, days 1, 8, and 15; followed by
Carboplatin AUC 2 mg/mL/min IV over 15 min, days 1, 8, and 15
Repeat every 28 days (4-week cycle) for 6 cycles
PLUS
Trastuzumab 4 mg/kg IV over 90 minutes on day 1 of cycle 1; followed by
Trastuzumab 6 mg/kg IV over 90 minutes every 21 days beginning with cycle 2 until disease progression 
TIP - Used for head and neck/esophageal cancer
Paclitaxel 175 mg/m(2) IV, over 3 hours, day 1
Ifosfamide 1000 mg/m(2) IV, over 2 hours, days 1 to 3
Mesna 400 mg/m(2) IV, before ifosfamide and 200 mg/m(2) IV, 4 hours after ifosfamide
Cisplatin 60 mg/m(2) IV, day 1
Repeat cycle every 21 to 28 days
TPC - Used for breast cancer
Cycle 1
Trastuzumab 4 mg/kg IV, day 1
Paclitaxel 175 mg/m(2) IV, day 2
Carboplatin AUC 6 mg/mL/min IV, day 2
Trastuzumab 2 mg/kg IV, days 8, 15
Cycles 2 through 6
Trastuzumab 2 mg/kg IV, days 1, 8, and 15
Paclitaxel 175 mg/m(2) IV, day 2
Carboplatin AUC 6 mg/mL/min IV, day 2
Repeat every 21 days for at least 6 cycles
After chemotherapy
Trastuzumab 2 mg/kg/week IV until disease progression or other discontinuation event 
VAD - Used for multiple myeloma
Vincristine 0.4 mg/day (max 2 mg) continuous infusion, days 1 to 4
Doxorubicin 9 mg/m(2)/day continuous infusion, days 1 to 4
Dexamethasone 40 mg ORALLY, days 1 to 4, 9 to 12, and 17 to 20
Repeat cycle every 25 to 35 days
VAD induction therapy followed by maintenance with Interferon alfa 3 million units subQ 3 times/week in the evening followed by Prednisone 50 mg ORALLY, 3 times/week on the morning after interferon
VATH - Used for breast cancer
VinBLAStine 4.5 mg/m(2) IV, day 1
Doxorubicin 45 mg/m(2) IV, day 1
Thiotepa 12 mg/m(2) IV, day 1
Fluoxymesterone 10 mg ORALLY 3 times/day
Repeat cycle every 21 days
VBMCP - Used for multiple myeloma
Vincristine 1.2 mg/m(2) (max 2 mg) IV, day 1
Carmustine 20 mg/m(2) IV, day 1
Melphalan 8 mg/m(2) ORALLY, days 1 to 4
Cyclophosphamide 400 mg/m(2) IV, day 1
Prednisone 40 mg/m(2) ORALLY, days 1 to 7
Repeat cycle every 35 days 
VBMCP/VBAD/B - Used for multiple myeloma
Vincristine 0.03 mg/kg (max 2 mg) IV, day 1
Carmustine 0.5 mg/kg IV, day 1
Melphalan 0.25 mg/kg ORALLY, days 1 to 4
Cyclophosphamide 10 mg/kg IV, day 1 
Prednisone 1 mg/kg ORALLY on days 1 to 4, 0.5 mg/kg ORALLY on days 5 to 8, and 0.25 mg/kg ORALLY on days 9 to 12
Cycle length is 35 days
Vincristine 1 mg IV, day 1
Carmustine 30 mg/m(2) IV, day 1
Doxorubicin 40 mg/m(2) IV, day 1
Dexamethasone 40 mg ORALLY, days 1 to 4, 9 to 12, and 17 to 20
Alternate courses at 5-week intervals for 4 cycles , then
Bortezomib 1.3 mg/m(2) IV, days 1, 4, 8, and 11 at 3-week intervals for 2 courses as induction therapy
Low-molecular weight heparin or aspirin thromboprophylaxis recommended 
VTD - Used for multiple myeloma
Bortezomib 1.3 mg/m(2) IV, days 1, 4, 8, and 11
Thalidomide 50 mg ORALLY on days 1 to 14, and 100 mg ORALLY on days 15 to 28 of cycle 1, then 200 mg ORALLY daily
Dexamethasone 40 mg ORALLY, days 1 to 4 and 9 to 12
Cycle length is 4 weeks, repeat for 6 cycles as induction therapy
Low-molecular weight heparin or aspirin thromboprophylaxis recommended 
Vinorelbine Cis - Used for lung cancer, non-small cell
Vinorelbine 30 mg/m(2) IV, every 7 days
Cisplatin 120 mg/m(2) IV, day 1 and 29, then every 6 weeks
Vinorelbine Doxorubicin - Used for breast cancer
Vinorelbine 25 mg/m(2) IV, days 1 and 8
Doxorubicin 50 mg/m(2) IV, day 1
Repeat cycle every 21 days
Vinorelbine Trastuzumab - Used for breast cancer
Trastuzumab 4 mg/kg IV, day 1, then 2 mg/kg IV, 1 times weekly
Vinorelbine 25 mg/m(2) IV, 1 times weekly on same day as trastuzumab 
VIP - Used for testicular cancer
VinBLAStine 0.11 mg/kg IV, days 1 and 2
OR
Etoposide 75 mg/m(2) IV, days 1 to 5
AND
Ifosfamide 1200 mg/m(2) IV, days 1 to 5
Cisplatin 20 mg/m(2) IV, days 1 to 5
Mesna 400 mg IV, 15 minutes prior to ifosfamide, then 1200 mg/day continuous infusion, days 1 to 5
Repeat cycle every 21 days
XELOX - Used for colon cancer
Capecitabine 1000 mg/m(2) ORALLY 2 times a day, days 1 to 14
Oxaliplatin 130 mg/m(2) IV over 2 hours, day 1
Repeat cycle every 21 days